KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jan 22, 2016 $159.15 $159.15 $159.15 $159.15 1 131 600
Jan 21, 2016 $155.52 $155.52 $155.52 $155.52 1 773 900
Jan 20, 2016 $159.89 $159.89 $159.89 $159.89 2 955 800
Jan 19, 2016 $156.75 $156.75 $156.75 $156.75 2 389 000
Jan 15, 2016 $158.68 $158.68 $158.68 $158.68 2 685 600
Jan 14, 2016 $167.29 $167.29 $167.29 $167.29 2 666 400
Jan 13, 2016 $157.92 $157.92 $157.92 $157.92 1 660 300
Jan 12, 2016 $166.12 $166.12 $166.12 $166.12 1 449 100
Jan 11, 2016 $161.65 $161.65 $161.65 $161.65 1 904 000
Jan 08, 2016 $168.13 $168.13 $168.13 $168.13 1 748 900
Jan 07, 2016 $174.37 $174.37 $174.37 $174.37 1 956 100
Jan 06, 2016 $184.07 $184.07 $184.07 $184.07 1 478 600
Jan 05, 2016 $184.90 $184.90 $184.90 $184.90 1 042 400
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT